However, the downregulation of another key member, RIPK3, is associated with low survival in acute myeloid leukemia, suggesting its antitumor effects through facilitating RIPK3-MLKL-mediated necroptosis and the differentiation of leukemia-initiating cells [12]. The gene discussed is RIPK3; the disease is acute myeloid leukemia.